Inspire Medical Systems, Inc. SEC filings INSP

Inspire Medical Systems, Inc. has 897 filings in SEC EDGAR's recent list, going back to May 30, 2014. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Inspire Medical Systems, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2026 Nov 2, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 30, 2026 —
4 Insider transaction Oct 16, 2026 Oct 14, 2026
4 Insider transaction Oct 16, 2026 Oct 14, 2026
4 Insider transaction Oct 16, 2026 Oct 14, 2026
4 Insider transaction Oct 16, 2026 Oct 14, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
144 Notice of proposed sale Aug 24, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 12, 2026 —
4 Insider transaction Aug 11, 2026 Aug 7, 2026
144 Notice of proposed sale Aug 7, 2026 —
4 Insider transaction Aug 4, 2026 Jul 31, 2025
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 3, 2026 Aug 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 28, 2026 —
4 Insider transaction Jul 27, 2026 Jul 20, 2026
3 Initial insider ownership Jul 27, 2026 Jul 20, 2026
8-K Current report
Officer or director change
Jul 24, 2026 Jul 20, 2026
8-K Current report
Officer or director change
Jul 22, 2026 Jul 16, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 2, 2026 —
8-K Current report
Regulation FD disclosure
Jun 26, 2026 Jun 26, 2026
SD Specialized disclosure (conflict minerals) Jun 1, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 27, 2026 —
4 Insider transaction May 19, 2026 May 15, 2026
144 Notice of proposed sale May 15, 2026 —
4 Insider transaction May 15, 2026 May 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
144 Notice of proposed sale May 14, 2026 —
4 Insider transaction May 11, 2026 May 8, 2026
144 Notice of proposed sale May 8, 2026 —
S-8 Employee stock plan registration May 7, 2026 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
May 5, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
10-Q Quarterly report May 4, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 4, 2026 May 4, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
ARS Annual report to shareholders Mar 20, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 20, 2026 —
DEF 14A Proxy statement Mar 20, 2026 Apr 30, 2026
PRE 14A Preliminary proxy statement Mar 9, 2026 Apr 30, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
3 Initial insider ownership Feb 24, 2026 Feb 17, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
10-K Annual report Feb 13, 2026 Dec 31, 2025
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
3 Initial insider ownership Feb 11, 2026 Jan 9, 2026
8-K Current report
Results of operations, Bylaw or fiscal year change, Regulation FD disclosure
Feb 11, 2026 Feb 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 10, 2026 —
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Jan 12, 2026 Jan 9, 2026
4 Insider transaction Jan 12, 2026 Jan 9, 2026
144 Notice of proposed sale Jan 9, 2026 —
4 Insider transaction Dec 4, 2025 Dec 2, 2025
144 Notice of proposed sale Dec 2, 2025 —
4 Insider transaction Dec 1, 2025 Nov 28, 2025
144 Notice of proposed sale Nov 28, 2025 —
4 Insider transaction Nov 24, 2025 Mar 20, 2025
8-K Current report
Other events
Nov 17, 2025 Nov 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 3, 2025 Nov 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 17, 2025 —
4 Insider transaction Oct 16, 2025 Oct 14, 2025
4 Insider transaction Oct 16, 2025 Oct 14, 2025
4 Insider transaction Oct 16, 2025 Oct 14, 2025
4 Insider transaction Oct 16, 2025 Oct 14, 2025
8-K Current report
Regulation FD disclosure
Oct 10, 2025 Oct 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 7, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 6, 2025 —
4 Insider transaction Sep 2, 2025 Aug 29, 2025
144 Notice of proposed sale Aug 29, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 26, 2025 Aug 22, 2025
4 Insider transaction Aug 21, 2025 Aug 19, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
8-K Current report
Other events
Aug 11, 2025 Aug 11, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Aug 4, 2025 Aug 4, 2025
4 Insider transaction Jul 16, 2025 Jul 15, 2025
4 Insider transaction Jul 16, 2025 Jul 15, 2025
4 Insider transaction Jul 16, 2025 Jul 15, 2025
4 Insider transaction Jul 16, 2025 Jul 15, 2025
8-K Current report
Regulation FD disclosure
Jun 13, 2025 Jun 13, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
SD Specialized disclosure (conflict minerals) May 30, 2025 —
4 Insider transaction May 21, 2025 May 19, 2025
144 Notice of proposed sale May 19, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 13, 2025 —
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Shareholder vote results
May 5, 2025 May 1, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 5, 2025 May 5, 2025
144 Notice of proposed sale May 2, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 30, 2025 —
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
ARS Annual report to shareholders Mar 18, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 18, 2025 —
DEF 14A Proxy statement Mar 18, 2025 May 1, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Feb 28, 2025 —
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 24, 2025 Feb 13, 2025
3 Initial insider ownership Feb 24, 2025 Jan 20, 2025
4 Insider transaction Feb 18, 2025 Feb 9, 2025
4 Insider transaction Feb 18, 2025 Feb 9, 2025
4 Insider transaction Feb 18, 2025 Jan 29, 2025
4 Insider transaction Feb 18, 2025 Feb 9, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 9, 2025
4 Insider transaction Feb 13, 2025 Feb 9, 2025
144 Notice of proposed sale Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
144 Notice of proposed sale Feb 11, 2025 —
10-K Annual report Feb 10, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 10, 2025 Feb 10, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 10, 2025 Jan 7, 2025
144 Notice of proposed sale Jan 7, 2025 —
4 Insider transaction Dec 23, 2024 Dec 20, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
8-K Current report
Other events
Nov 12, 2024 Nov 8, 2024
4 Insider transaction Nov 5, 2024 Nov 1, 2024
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2024 Nov 4, 2024
144 Notice of proposed sale Nov 1, 2024 —
4 Insider transaction Oct 16, 2024 Oct 14, 2024
4 Insider transaction Oct 16, 2024 Oct 14, 2024
4 Insider transaction Oct 16, 2024 Oct 14, 2024
4 Insider transaction Oct 16, 2024 Oct 14, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 7, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 4, 2024 —
144 Notice of proposed sale Sep 11, 2024 —
4 Insider transaction Sep 11, 2024 Sep 9, 2024
4 Insider transaction Sep 11, 2024 Sep 9, 2024
144 Notice of proposed sale Sep 9, 2024 —
144 Notice of proposed sale Sep 9, 2024 —
4 Insider transaction Aug 23, 2024 Aug 22, 2024
144 Notice of proposed sale Aug 22, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
INSP (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Golden Valley, MN
SEC filer status
Large accelerated filer
SEC CIK
1609550

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.